Dow Up 0.76% Nasdaq Up 0.69%

Novogen Limited (NVGN)

-NasdaqCM
2.88 Down 0.05(1.71%) Oct 24, 3:59PM EDT
Prev Close:2.93
Open:2.89
Bid:N/A
Ask:5.38 x 200
1y Target Est:N/A
Beta:-1.58
Next Earnings Date:N/A
Day's Range:2.86 - 3.03
52wk Range:2.68 - 6.84
Volume:18,490
Avg Vol (3m):12,056
Market Cap:19.42M
P/E (ttm):N/A
EPS (ttm):-1.05
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for NVGN

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):52.55
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:N/A
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Novogen Limited is engaged in the pharmaceutical research and development business in Australia. The company has primarily two drug technology platforms, which include super-benzopyrans (SBPs) and anti-tropomyosins (ATMs). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback